WATSON 415 (Estropipate 1.5 mg)
Pill with imprint WATSON 415 is Orange, Round and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.
Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 415
Estropipate
- Imprint
- WATSON 415
- Strength
- 1.5 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Estrogens
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 52544-0415
More about estropipate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 7 Reviews
- Drug class: estrogens
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.